Compound Summary
Compound Name: | Phenelzine |
Compound CID: | 3675 |
Synonyms: | Phenelzine Phenethylhydrazine 51-71-8 2-Phenylethylhydrazine Nardil More... |
Iupac Name: | 2-phenylethylhydrazine |
InChI: | InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2 |
InChIKey: | RMUCZJUITONUFY-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC=C(C=C1)CCNN |
Isomeric Smiles: | C1=CC=C(C=C1)CCNN |
Molecular Weight: | 136.19 |
Molecular Formula: | C8H12N2 |
Molecular Weight: | 136.19 |
Molecular Formula: | C8H12N2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 10 |
Complexity: | 77.3 |
Phenelzine | Phenelzine |
---|---|
Phenelzine |
Phenethylhydrazine |
51-71-8 |
2-Phenylethylhydrazine |
Nardil |
Hydrazine, (2-phenylethyl)- |
Fenelzyna |
Fenelzyne |
beta-Phenylethylhydrazine |
Phenelzinum |
2-Phenethylhydrazine |
1-Hydrazino-2-phenylethane |
Phenethyl-hydrazine |
(2-phenylethyl)hydrazine |
HYDRAZINE, PHENETHYL- |
W 1544-A |
phenethyl hydrazine |
UNII-O408N561GF |
(2-Phenyl-ethyl)-hydrazine |
CHEMBL1089 |
CHEBI:8060 |
O408N561GF |
Fenelzina INN-Spanish |
Fenelzyna Polish |
Fenelzyne Polish |
Phenelzinum INN-Latin |
Fenelzina |
Phenelzine INN:BAN |
Phenylethylhydrazine |
Phenelzine (BAN) |
EINECS 200-117-9 |
BRN 0742354 |
HSDB 8127 |
Nardil (Salt/Mix) |
Spectrum_000851 |
Prestwick0_000170 |
Prestwick1_000170 |
Prestwick2_000170 |
Prestwick3_000170 |
Spectrum2_001009 |
Spectrum3_000677 |
Spectrum4_000475 |
Spectrum5_000990 |
Lopac-P-6777 |
1-(2-phenethyl)hydrazine |
CBChromo1_000176 |
.beta.-Phenylethylhydrazine |
1-(2-Phenylethyl)hydrazine |
Lopac0_000971 |
SCHEMBL34335 |
BSPBio_000039 |
BSPBio_002373 |
KBioGR_000950 |
KBioGR_002265 |
KBioSS_001331 |
KBioSS_002266 |
4-15-00-01269 (Beilstein Handbook Reference) |
DivK1c_000062 |
SPBio_001137 |
SPBio_001960 |
1-(2-Phenylethyl)hydrazine # |
BPBio1_000043 |
GTPL7266 |
DTXSID2041094 |
KBio1_000062 |
KBio2_001331 |
KBio2_002265 |
KBio2_003899 |
KBio2_004833 |
KBio2_006467 |
KBio2_007401 |
KBio3_001593 |
KBio3_002745 |
cMAP_000003 |
NINDS_000062 |
HMS3259L04 |
HY-B1018 |
4752AE |
BDBM50105417 |
MFCD00047825 |
ZINC19166991 |
AKOS000131105 |
CCG-205051 |
CS-4532 |
DB00780 |
MCULE-2911295500 |
NC00692 |
SDCCGSBI-0050944.P005 |
IDI1_000062 |
NCGC00015830-01 |
NCGC00015830-03 |
NCGC00015830-04 |
NCGC00015830-05 |
NCGC00015830-07 |
NCGC00015830-13 |
NCGC00162301-01 |
AS-77074 |
SBI-0050944.P004 |
DB-052010 |
AB00053520 |
FT-0631225 |
C07430 |
D08349 |
W-1544 |
AB00053520_12 |
047P825 |
A828737 |
Q1747559 |
BRD-K87024524-065-05-2 |
14847-47-3 |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drosophila melanogaster | 20.000000000000000 | umol/L | 45.440000000000000 | 44.900000000000000 | -1.182000000000000 | NS | FEMALES | 33008901 | Inactive | ||||
Drosophila melanogaster | 200.000000000000000 | umol/L | 44.800000000000000 | 42.410000000000000 | -5.347000000000000 | NS | MALES | 33008901 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Drosophila melanogaster | -1.182000000000000 | 1 | 2 |